BioEnterprise, a Cleveland-based site that tracks health care and bioscience ventures, reports that the amount of capital raised in the Twin Cities has slowed, with $69 million raised so far this year. That's a drop from $86 million in the same time one year ago. Minnesota still ranked second in the Midwest, behind Ohio which raised about $155 million.
At the same time, BioEnterprise reported that the number of deals bolted up, from 9 to 45. The Business Journal concludes that it may be the first time that data from Minnesota's angel-investor tax credit program was factored into the count.